← FDA DRUG APPROVALS

FDA ANDA · ANDA077850

NICOTINE POLACRILEX

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA077850
TYPE
ANDA
ORIGINAL APPROVAL
2009-02-18
LATEST ACTION
2013-09-19
ROUTE
BUCCAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Discontinued

Products

NICOTINE POLACRILEXDiscontinued
NICOTINE POLACRILEX EQ 4MG BASE · GUM, CHEWING · BUCCAL

Approval history

2013-09-19Labeling · Supplement 3 · standardAP
2012-11-20Labeling · Supplement 2AP
2009-02-18OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →